In vitro inhibitory effects of non-steroidal anti-inflammatory drugs on 4-methylumbelliferone glucuronidation in recombinant human UDP-glucuronosyltransferase 1A9--potent inhibition by niflumic acid
Copyright (c) 2005 John Wiley & Sons, Ltd..
The inhibitory potencies of non-steroidal anti-inflammatory drugs (NSAIDs) on UDP-glucuronosyltransferase (UGT) 1A9 activity were investigated in recombinant human UGT1A9 using 4-methylumbelliferone (4-MU) as a substrate for glucuronidation. 4-MU glucuronidation (4-MUG) showed Michaelis-Menten kinetics with a Km value of 6.7 microM. The inhibitory effects of the following seven NSAIDs were investigated: acetaminophen, diclofenac, diflunisal, indomethacin, ketoprofen, naproxen and niflumic acid. Niflumic acid had the most potent inhibitory effect on 4-MUG with an IC50 value of 0.0341 microM. The IC50 values of diflunisal, diclofenac and indomethacin were 1.31, 24.2, and 34.1 microM, respectively, while acetaminophen, ketoprofen and naproxen showed less potent inhibition. Niflumic acid, diflunisal, diclofenac and indomethacin inhibited 4-MUG competitively with Ki values of 0.0275, 0.710, 53.3 and 69.9 microM, respectively, being similar to each IC50 value. In conclusion, of the seven NSAIDs investigated, niflumic acid was the most potent inhibitor of recombinant UGT1A9 via 4-MUG in a competitive manner.
Medienart: |
Artikel |
---|
Erscheinungsjahr: |
2006 |
---|---|
Erschienen: |
2006 |
Enthalten in: |
Zur Gesamtaufnahme - volume:27 |
---|---|
Enthalten in: |
Biopharmaceutics & drug disposition - 27(2006), 1 vom: 16. Jan., Seite 1-6 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Mano, Yuji [VerfasserIn] |
---|
Anmerkungen: |
Date Completed 20.04.2006 Date Revised 03.12.2021 published: Print Citation Status MEDLINE |
---|
Förderinstitution / Projekttitel: |
|
---|
PPN (Katalog-ID): |
NLM15885117X |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM15885117X | ||
003 | DE-627 | ||
005 | 20231223083005.0 | ||
007 | tu | ||
008 | 231223s2006 xx ||||| 00| ||eng c | ||
028 | 5 | 2 | |a pubmed24n0530.xml |
035 | |a (DE-627)NLM15885117X | ||
035 | |a (NLM)16278927 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Mano, Yuji |e verfasserin |4 aut | |
245 | 1 | 0 | |a In vitro inhibitory effects of non-steroidal anti-inflammatory drugs on 4-methylumbelliferone glucuronidation in recombinant human UDP-glucuronosyltransferase 1A9--potent inhibition by niflumic acid |
264 | 1 | |c 2006 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
338 | |a Band |b nc |2 rdacarrier | ||
500 | |a Date Completed 20.04.2006 | ||
500 | |a Date Revised 03.12.2021 | ||
500 | |a published: Print | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright (c) 2005 John Wiley & Sons, Ltd. | ||
520 | |a The inhibitory potencies of non-steroidal anti-inflammatory drugs (NSAIDs) on UDP-glucuronosyltransferase (UGT) 1A9 activity were investigated in recombinant human UGT1A9 using 4-methylumbelliferone (4-MU) as a substrate for glucuronidation. 4-MU glucuronidation (4-MUG) showed Michaelis-Menten kinetics with a Km value of 6.7 microM. The inhibitory effects of the following seven NSAIDs were investigated: acetaminophen, diclofenac, diflunisal, indomethacin, ketoprofen, naproxen and niflumic acid. Niflumic acid had the most potent inhibitory effect on 4-MUG with an IC50 value of 0.0341 microM. The IC50 values of diflunisal, diclofenac and indomethacin were 1.31, 24.2, and 34.1 microM, respectively, while acetaminophen, ketoprofen and naproxen showed less potent inhibition. Niflumic acid, diflunisal, diclofenac and indomethacin inhibited 4-MUG competitively with Ki values of 0.0275, 0.710, 53.3 and 69.9 microM, respectively, being similar to each IC50 value. In conclusion, of the seven NSAIDs investigated, niflumic acid was the most potent inhibitor of recombinant UGT1A9 via 4-MUG in a competitive manner | ||
650 | 4 | |a Comparative Study | |
650 | 4 | |a Journal Article | |
650 | 7 | |a Anti-Inflammatory Agents, Non-Steroidal |2 NLM | |
650 | 7 | |a Enzyme Inhibitors |2 NLM | |
650 | 7 | |a Glucuronides |2 NLM | |
650 | 7 | |a Recombinant Proteins |2 NLM | |
650 | 7 | |a UGT1A9 protein, human |2 NLM | |
650 | 7 | |a Diclofenac |2 NLM | |
650 | 7 | |a 144O8QL0L1 |2 NLM | |
650 | 7 | |a Hymecromone |2 NLM | |
650 | 7 | |a 3T5NG4Q468 |2 NLM | |
650 | 7 | |a Niflumic Acid |2 NLM | |
650 | 7 | |a 4U5MP5IUD8 |2 NLM | |
650 | 7 | |a Diflunisal |2 NLM | |
650 | 7 | |a 7C546U4DEN |2 NLM | |
650 | 7 | |a Glucuronosyltransferase |2 NLM | |
650 | 7 | |a EC 2.4.1.17 |2 NLM | |
650 | 7 | |a UDP-Glucuronosyltransferase 1A9 |2 NLM | |
650 | 7 | |a EC 2.4.1.17 |2 NLM | |
700 | 1 | |a Usui, Takashi |e verfasserin |4 aut | |
700 | 1 | |a Kamimura, Hidetaka |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Biopharmaceutics & drug disposition |d 1994 |g 27(2006), 1 vom: 16. Jan., Seite 1-6 |w (DE-627)NLM003938654 |x 1099-081X |7 nnns |
773 | 1 | 8 | |g volume:27 |g year:2006 |g number:1 |g day:16 |g month:01 |g pages:1-6 |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 27 |j 2006 |e 1 |b 16 |c 01 |h 1-6 |